Itoh T - Search Results

1

Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.

Imura K, Ueda Y, Hayashi T, Itoh T, Shimizu K, Tamai H, Yano Y, Naito K, Kohara J, Nakane K, Matsuura Y, Takeda A, Takeda T, Kawai K, Yamagishi H. Imura K, et al. Among authors: itoh t. Int J Oncol. 2006 Sep;29(3):531-9. Int J Oncol. 2006. PMID: 16865268

2

Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.

Ueda Y, Itoh T, Nukaya I, Kawashima I, Okugawa K, Yano Y, Yamamoto Y, Naitoh K, Shimizu K, Imura K, Fuji N, Fujiwara H, Ochiai T, Itoi H, Sonoyama T, Hagiwara A, Takesako K, Yamagishi H. Ueda Y, et al. Among authors: itoh t. Int J Oncol. 2004 Apr;24(4):909-17. Int J Oncol. 2004. PMID: 15010829 Clinical Trial.

3

Mobilization of peripheral blood stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in advanced gastric cancer.

Ueda Y, Sonoda Y, Fujiki H, Harada S, Kimura T, Itoh T, Imura K, Naito K, Nomura K, Taniwaki M, Yamagishi H. Ueda Y, et al. Among authors: itoh t. Oncol Rep. 2004 Aug;12(2):323-32. Oncol Rep. 2004. PMID: 15254697

4

Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.

Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y. Okugawa K, et al. Among authors: itoh t. Oncol Rep. 2004 Oct;12(4):725-31. Oncol Rep. 2004. PMID: 15375491

5

Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.

Naito K, Ueda Y, Itoh T, Fuji N, Shimizu K, Yano Y, Yamamoto Y, Imura K, Kohara J, Iwamoto A, Shiozaki A, Tamai H, Shimizu T, Mazda O, Yamagishi H. Naito K, et al. Among authors: itoh t. Int J Oncol. 2006 Jun;28(6):1481-9. Int J Oncol. 2006. PMID: 16685449

6

Induction of peptide-specific immune response in patients with primary malignant melanoma of the esophagus after immunotherapy using dendritic cells pulsed with MAGE peptides.

Ueda Y, Shimizu K, Itoh T, Fuji N, Naito K, Shiozaki A, Yamamoto Y, Shimizu T, Iwamoto A, Tamai H, Yamagishi H. Ueda Y, et al. Among authors: itoh t. Jpn J Clin Oncol. 2007 Feb;37(2):140-5. doi: 10.1093/jjco/hyl136. Epub 2007 Jan 25. Jpn J Clin Oncol. 2007. PMID: 17255158

7

Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen.

Itoh T, Ueda Y, Kawashima I, Nukaya I, Fujiwara H, Fuji N, Yamashita T, Yoshimura T, Okugawa K, Iwasaki T, Ideno M, Takesako K, Mitsuhashi M, Orita K, Yamagishi H. Itoh T, et al. Cancer Immunol Immunother. 2002 Apr;51(2):99-106. doi: 10.1007/s00262-001-0257-z. Epub 2002 Jan 30. Cancer Immunol Immunother. 2002. PMID: 11904734 Free PMC article.

8

Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy.

Ueda Y, Itoh T, Fuji N, Harada S, Fujiki H, Shimizu K, Shiozaki A, Iwamoto A, Shimizu T, Mazda O, Kimura T, Sonoda Y, Taniwaki M, Yamagishi H. Ueda Y, et al. Among authors: itoh t. Cancer Immunol Immunother. 2007 Mar;56(3):381-9. doi: 10.1007/s00262-006-0197-8. Epub 2006 Jul 8. Cancer Immunol Immunother. 2007. PMID: 16830156 Free PMC article. Clinical Trial.

9

The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomas.

Ueda Y, Shiozaki A, Itoi H, Okamoto K, Fujiwara H, Ichikawa D, Kikuchi S, Fuji N, Itoh T, Ochiai T, Yamagishi H. Ueda Y, et al. Among authors: itoh t. Jpn J Clin Oncol. 2006 Dec;36(12):775-82. doi: 10.1093/jjco/hyl105. Epub 2006 Oct 16. Jpn J Clin Oncol. 2006. PMID: 17043058

10

A novel immunotherapeutic modality with direct hemoperfusion targeting transforming growth factor-beta prolongs the survival of tumor-bearing rats.

Yamamoto Y, Ueda Y, Itoh T, Iwamoto A, Yamagishi H, Shimagaki M, Teramoto K. Yamamoto Y, et al. Among authors: itoh t. Oncol Rep. 2006 Dec;16(6):1277-84. Oncol Rep. 2006. PMID: 17089050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,371 results

Search Page

Filters